Advertisement

Leucovorin Calcium Injection

[02 December 2016]

Products Affected - Description

Leucovorin Calcium Lyophilized Powder for Injection, Fresenius Kabi
200 mg, vial, 1 count (NDC 63323-0710-50)
500 mg vial, 1 count (NDC 63323-0711-00)
 
Leucovorin Calcium lyophilized powder for solution for injection, Sagent
50 mg, vial, 10 count (NDC 25021-0813-10)
100 mg, vial, 10 count (NDC 25021-0814-30)
200 mg, vial, 1 count (NDC 25021-0815-30)
350 mg, vial, 1 count (NDC 25021-0816-30)
 
Leucovorin Calcium lyophilized powder for solution for injection, Teva
100 mg, vial, 1 count (NDC 00703-5140-01)
350 mg, vial, 1 count (NDC 00703-5145-01)

Reason for the Shortage

  • Fresenius Kabi has leucovorin on shortage due to increase demand.
  • Teva has leucovorin on allocation due to increased demand.
  • West-Ward has leucovorin available.
  • Sagent has leucovorin on shortage due to manufacturing delay.

Available Products

Leucovorin Calcium lyophilized powder for solution for injection, West-Ward
350 mg, vial, 1 count (NDC 00143-9552-01)

Estimated Resupply Dates

  • Fresenius Kabi has leucovorin 200 mg and 500 mg vials on back order and the company estimates a release date of early-December 2016 for the 200 mg vials and mid-December 2016 for the 500 mg vials.
  • Sagent has leucovorin 200 mg and 350 mg vials on back order and the company estimates a release date of December 2016. The 50 mg vials are on allocation. The 100 mg vials are available with an expiration date of January 2017.
  • Teva has leucovorin 100 mg and 350 mg vials on allocation.

Related Shortages

Updated

December 2, November 9, September 29 and 6, August 3, July 26, May 3, February 25 and 1, January 20, 2016; December 17, November 18, September 29, August 4, July 23, June 22 and 2, April 30, March 23, February 27, January 22, 2015; December 22, November 19, October 31 and 14, September 24, August 26, July 21, June 26, May 21, April 24, March 31, February 7, January 15, 2014; November 27, September 12, August 28, July 31, June 18, May 28, April 19, March 21, February 22, January 22, 2013; December 18, November 7, October 1, August 30 July 5, June 1, May 10, April 6, March 29, February 23, January 30, 2012; November 10, September 30, August 31, July 22, June 29, May 20, April 19, March 30, February 11, January 20, 2011; December 16, November 8, October 14, September 17, August 18, July 20, June 30, 2010, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing